journal
Journals Current Opinion in Allergy and...

Current Opinion in Allergy and Clinical Immunology

https://read.qxmd.com/read/37767915/monogenic-forms-of-common-variable-immunodeficiency-and-implications-on-target-therapeutic-approaches
#1
JOURNAL ARTICLE
Giulio Tessarin, Manuela Baronio, Vassilios Lougaris
PURPOSE OF REVIEW: Common variable immunodeficiency (CVID) is the most common symptomatic inborn error of immunity. The disorder is characterized by variable clinical and immunological manifestations, and, in a small minority of patients, a monogenic cause may be identified. In this review, we focalized on three different monogenic forms of CVID-like disease. RECENT FINDINGS: Activated phosphoinositide 3-kinase delta syndrome (APDS) is a rare disorder characterized by hyperactivated class I phosphatidylinositol-3 kinase (PI3K) pathway...
September 29, 2023: Current Opinion in Allergy and Clinical Immunology
https://read.qxmd.com/read/37755421/atopic-manifestations-of-inborn-errors-of-immunity
#2
JOURNAL ARTICLE
Laura Sams, Sonali Wijetilleka, Mark Ponsford, Andrew Gennery, Stephen Jolles
PURPOSE OF REVIEW: Allergy and atopic features are now well recognized manifestations of many inborn errors of immunity (IEI), and indeed may be the hallmark in some, such as DOCK8 deficiency. In this review, we describe the current IEI associated with atopy, using a comprehensive literature search and updates from the IUIS highlighting clinical clues for underlying IEI such as very early onset of atopic disease or treatment resistance to enable early and accurate genetic diagnosis. RECENT FINDINGS: We focus on recently described genes, their categories of pathogenic mechanisms and the expanding range of potential therapies...
September 27, 2023: Current Opinion in Allergy and Clinical Immunology
https://read.qxmd.com/read/37712561/effects-of-allergen-immunotherapy-on-follicular-regulatory-t-cells
#3
JOURNAL ARTICLE
Shi-Ran Sun, Yin Yao, Zheng Liu
PURPOSE OF REVIEW: Emerging evidence indicating that the dysfunction of T follicular regulatory (T FR ) cells contributes to excessive immunoglobulin E (IgE) production and the development of allergic diseases. Conversely, allergen immunotherapy (AIT) modulates T FR cells abundance and function to promote immune tolerance. This review focus on the role of T FR cells in allergic diseases and AIT, with the objective of providing novel insights into the mechanisms underlying immune tolerance of AIT and proposing the potential targeting of T FR cells in the context of allergic diseases...
September 18, 2023: Current Opinion in Allergy and Clinical Immunology
https://read.qxmd.com/read/37694830/neurotrophic-keratitis-inflammatory-pathogenesis-and-novel-therapies
#4
JOURNAL ARTICLE
Denise Wajnsztajn, Lana A Faraj, Sara Sanchez-Tabernero, Abraham Solomon
PURPOSE OF REVIEW: Neurotrophic keratitis is a rare degenerative disease characterized by decrease or absence of corneal sensation. Neurotrophic keratitis varies from mild forms with mild epitheliopathy to severe manifestations such as corneal ulceration, melting and perforation that can lead to irreversible visual loss. The cause of neurotrophic keratitis comprises a long list of diseases, medications, congenital or genetic conditions as well as trauma. The mechanism of neurotrophic keratitis is complex and multifactorial and its understanding is crucial to better address the treatment strategies...
September 8, 2023: Current Opinion in Allergy and Clinical Immunology
https://read.qxmd.com/read/37493235/ocular-involvement-in-allergic-drug-reactions
#5
JOURNAL ARTICLE
Edward Fernandez, Elizabeth Phillips, Hajirah N Saeed
PURPOSE OF REVIEW: Many systemic medications have been observed to cause ocular toxicity. A subset of these reactions is thought to involve immunomodulation or a hypersensitivity reaction. As new medications are developed, ocular adverse effects are becoming increasingly prevalent. Herein we review immune-mediated drug reactions affecting they eye with special attention to the hypersensitivity mechanisms leading to ocular toxicity. RECENT FINDINGS: Recent work has focused on mechanisms and risk of immune-mediated ocular adverse drug reactions including genetic susceptibility and loss of ocular immune privilege...
July 27, 2023: Current Opinion in Allergy and Clinical Immunology
https://read.qxmd.com/read/37490616/ocular-surface-itch-and-pain-key-differences-and-similarities-between-the-two-sensations
#6
JOURNAL ARTICLE
Shyamal Raolji, Preet Kumar, Anat Galor
PURPOSE OF REVIEW: To review the pathophysiology and treatment of ocular itch and pain, encompassing nociceptive and neuropathic categories. RECENT FINDINGS: Ocular itch and pain are sensations that arise from activation of ocular surface polymodal nerves. Nociceptive itch, commonly comorbid with ocular pain complaints, is mainly driven by a histamine-mediated type 1 hypersensitivity reaction. Beyond topical therapy, novel drug delivery systems are being explored to improve ocular residence time of nonsteroidal anti-inflammatory drugs (NSAIDs) and antihistamines...
July 25, 2023: Current Opinion in Allergy and Clinical Immunology
https://read.qxmd.com/read/37490610/ocular-surface-inflammation-and-ectatic-corneal-disorders
#7
JOURNAL ARTICLE
Nir Erdinest, Denise Wajnsztajn, Naomi London, Abraham Solomon
PURPOSE OF REVIEW: Inflammatory mediators are a focus of recent corneal ectasia (CE) research and are a profound, modifiable contributor to CE in general and keratoconus (KC) in particular, opening a path to explore new methods of control. As advanced imaging technology and expanded population screening allow for earlier detection, the possibility of early intervention can profoundly change the prognosis of CE. RECENT FINDINGS: Significant increases in the inflammatory mediators and immune components have been observed in the cornea, tear fluid, and blood of ectasia patients, while inflammation dampeners such as vitamin D and their receptors are reduced...
July 25, 2023: Current Opinion in Allergy and Clinical Immunology
https://read.qxmd.com/read/37490617/new-arrivals-in-anaphylaxis-to-foods
#8
JOURNAL ARTICLE
Bianca Olivieri, Isabel J Skypala
PURPOSE OF REVIEW: More people are excluding wheat from their diet, or turning to a more sustainable diet in which includes meat substitutes or is mainly or wholly plant-based. This increases the availability of new foods and with it the increasing likelihood of novel allergens. RECENT FINDINGS: There is a growing body of evidence which suggests that allergies to seeds and legumes are increasing potentially due to their use in concentrated form in vegan or health foods...
July 20, 2023: Current Opinion in Allergy and Clinical Immunology
https://read.qxmd.com/read/37459276/role-of-the-ocular-surface-microbiome-in-allergic-eye-diseases-invited-review-for-current-opinion-in-allergy-clinical-immunology
#9
JOURNAL ARTICLE
Kara M Cavuoto, Anat Galor, Angela Y Zhu
PURPOSE OF REVIEW: The purpose of this review is to provide an update on emerging literature on the role of the ocular surface microbiome (OSM) in allergic eye diseases. RECENT FINDINGS: Findings in the literature suggest that the ocular surface microbiome plays a role in the pathophysiology and course of allergic disease of the ocular surface. SUMMARY: Knowledge regarding the role of the ocular surface microbiome in allergic disease is important to guide development of targets for future therapeutic interventions...
July 18, 2023: Current Opinion in Allergy and Clinical Immunology
https://read.qxmd.com/read/37641918/the-pathogenetic-role-of-th17-immune-response-in-atopic-dermatitis
#10
REVIEW
Eden David, Tali Czarnowicki
PURPOSE OF REVIEW: As we continue to unravel the pathophysiology and immune mechanisms underlying atopic dermatitis (AD), the emergence of targeted treatments has provided new options for management. Although there are available therapies targeting various immune pathways in AD, the precise pathogenic role of interleukin (IL)-17 in AD pathogenesis remains unclear. The objective of this review is to examine the existing data pertaining to the role of IL-17 in AD and shed light on the potential of targeting this pathway as a therapeutic approach in AD treatment...
October 1, 2023: Current Opinion in Allergy and Clinical Immunology
https://read.qxmd.com/read/37641917/anaphylaxis-unraveling-the-mysteries-and-new-perspectives
#11
JOURNAL ARTICLE
Gianenrico Senna, Bianca Olivieri, Mariana Castells
No abstract text is available yet for this article.
October 1, 2023: Current Opinion in Allergy and Clinical Immunology
https://read.qxmd.com/read/37641916/editorial-introductions
#12
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
October 1, 2023: Current Opinion in Allergy and Clinical Immunology
https://read.qxmd.com/read/37555938/anaphylaxis-due-to-antiallergic-and-antiasthmatic-biologics
#13
REVIEW
Fabiana Furci, Nicoletta Luxi, Gianenrico Senna, Gianluca Trifirò
PURPOSE OF REVIEW: To provide a better understanding of the risk of anaphylaxis due to antiallergic and antiasthmatic biologics through an analysis of data reported in literature and in clinical trials, and by conducting a retrospective descriptive analysis of individual case safety reports on VigiBase, the WHO International Pharmacovigilance database. RECENT FINDINGS: Analysis of the data, as described, demonstrated safety of the antiallergic and antiasthmatic biologics with a low incidence of anaphylaxis...
October 1, 2023: Current Opinion in Allergy and Clinical Immunology
https://read.qxmd.com/read/37548324/epidemiology-of-anaphylaxis-is-the-trend-still-going-up
#14
REVIEW
Luciana Kase Tanno, Marco Caminati, Guillaume Pouessel, Gianenrico Senna, Pascal Demoly
PURPOSE OF REVIEW: To understand the current global scale of anaphylaxis and identify possible strategies to increase the accuracy of epidemiological data. RECENT FINDINGS: Anaphylaxis mortality and morbidity statistics may gain new perspectives with the global implementation of the ICD-11. Improving the quality of epidemiological data related to anaphylaxis should clarify some areas of uncertainty about risk factors, leading to better targeting of strategies to protect those patients at risk, and support decision-making to facilitate health care planning and implementation of public health measures to prevent anaphylaxis...
October 1, 2023: Current Opinion in Allergy and Clinical Immunology
https://read.qxmd.com/read/37527059/biologics-to-treat-anaphylaxis
#15
REVIEW
Barbara C Yang
PURPOSE OF REVIEW: The purpose of this literature review was to review the latest use of biologics in the management of anaphylaxis. The methodology was to highlight both the nonbiologic management of anaphylaxis and the biologic management and how they can be used in conjunction with each other. RECENT FINDINGS: As the phenotypes and endotypes of anaphylaxis are better portrayed, it furthers our understanding of the mechanisms of anaphylaxis. New applications of existing biologics to the prevention of anaphylaxis are described...
October 1, 2023: Current Opinion in Allergy and Clinical Immunology
https://read.qxmd.com/read/37527055/atopic-dermatitis-and-ocular-allergy-common-mechanisms-and-uncommon-questions
#16
REVIEW
Debajyoti Ghosh, Tesfaye B Mersha
PURPOSE OF REVIEW: Atopic dermatitis (AD) and ocular allergy aka allergic eye disease (AED) are two common conditions that often coexist in patients. However, molecular connections between these two conditions are incompletely understood. While common etiologic components including Th2 immune signaling have been suggested for AD and AED, the mechanism how current Th2-targetd therapies (dupilumab, tralokinumab) for AD can augment conjunctivitis is not well understood. RECENT FINDINGS: Differentially regulated genes and pathways relevant for AD disease manifestation are known...
October 1, 2023: Current Opinion in Allergy and Clinical Immunology
https://read.qxmd.com/read/37459281/chronic-spontaneous-urticaria-new-evidences-on-the-role-of-autoimmunity
#17
REVIEW
Yi-Kui Xiang, Sercan Guloglu, Daniel Elieh-Ali-Komi, Emek Kocatürk
PURPOSE OF REVIEW: The purpose of this review is to provide an overview of the recent advancements and relevance of the autoimmune theories in chronic spontaneous urticaria (CSU). RECENT FINDINGS: Two primary types of autoimmunity, Type I and Type IIb, have emerged as major contributors to CSU, characterized by immunoglobulin E (IgE) and immunoglobulin G (IgG) autoantibodies, respectively. Genetic evidence supports the notion that CSU shares more similarities with other autoimmune diseases rather than atopic diseases...
October 1, 2023: Current Opinion in Allergy and Clinical Immunology
https://read.qxmd.com/read/37459277/the-use-of-environmental-exposure-chambers-in-studies-related-to-ocular-surface-effects
#18
REVIEW
Alina Gherasim, Leonard Bielory
PURPOSE OF REVIEW: The potential of allergen challenges using environmental exposure facilities in allergic conjunctivitis drug development and more recently its implication on the diagnosis of the united airways concept have been emphasized in the recent literature. This study aims to present an overview of new and important data in this field. RECENT FINDINGS: Standardized methodologies for ocular surface assessment during allergen challenges were described. The Total Ocular Symptom Score (TOSS) is the main validated questionnaire used for the assessment of ocular surface during allergen challenges...
October 1, 2023: Current Opinion in Allergy and Clinical Immunology
https://read.qxmd.com/read/37459274/prevalence-and-clinical-characteristics-of-vernal-keratoconjunctivitis-in-sub-saharan-africa
#19
REVIEW
Eleanor Ngwe Nche, Marvice Muyen Okwen, Abraham Solomon
PURPOSE OF REVIEW: Vernal keratoconjunctivitis (VKC) is a chronic bilateral allergic inflammatory disease of the conjunctiva and cornea that affects children and young adults, especially in sub-Saharan Africa. A limbal form (tropical endemic limbo conjunctivitis) is thought to be more common in the tropics where research on this vision-impairing condition is scanty. We sought to review current literature from sub-Saharan Africa, with a focus on the prevalence of VKC and its clinical presentation...
October 1, 2023: Current Opinion in Allergy and Clinical Immunology
https://read.qxmd.com/read/37633876/editorial-introductions
#20
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
August 1, 2023: Current Opinion in Allergy and Clinical Immunology
journal
journal
20090
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.